Immunic, inc. to announce financial results for the year ended december 31, 2022, and provide corporate update

– webcast to be held at 8:00 am et on february 23, 2023 – new york , feb. 16, 2023 /prnewswire/ -- immunic, inc. (nasdaq: imux), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, today announced that the company will release its financial results for the fourth quarter and year ended december 31, 2022, including a corporate update, on thursday, february 23, 2023, before the opening of the u.s. financial markets. a webcast will follow at 8:00 am et.
IMUX Ratings Summary
IMUX Quant Ranking